Clearside Biomedical Inc
NASDAQ:CLSD

Watchlist Manager
Clearside Biomedical Inc Logo
Clearside Biomedical Inc
NASDAQ:CLSD
Watchlist
Price: 0.7865 USD 1.48% Market Closed
Market Cap: 61.1m USD

Wall Street
Price Targets

CLSD Price Targets Summary
Clearside Biomedical Inc

There are no price targets for CLSD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Clearside Biomedical Inc Competitors:
Price Targets
AZN
AstraZeneca PLC
25% Upside
4577
Daito Pharmaceutical Co Ltd
2% Downside
300363
Porton Pharma Solutions Ltd
37% Upside
ORCHPHARMA
Orchid Pharma Ltd
42% Upside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
22% Upside
ENZY
Enzymatica AB (publ)
6% Downside
600267
Zhejiang Hisun Pharmaceutical Co Ltd
25% Downside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Clearside Biomedical Inc

For the last 8 years the compound annual growth rate for Clearside Biomedical Inc's revenue is 16%. The projected CAGR for the next 3 years is 107%.

16%
Past Growth
107%
Estimated Growth
Estimates Accuracy
11%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Clearside Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Clearside Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLSD's stock price target?
Not Available

CLSD doesn't have any price targets made by Wall Street professionals.

What is Clearside Biomedical Inc's Revenue forecast?
Projected CAGR
107%

For the last 8 years the compound annual growth rate for Clearside Biomedical Inc's revenue is 16%. The projected CAGR for the next 3 years is 107%.

Back to Top